Mechanistically, escin activates hippocampal miR-223 expression, resulting in inhibition of the NF‐κB pathway but enhancement of BDNF/TrkB pathway activity, thereby reducing neuroinflammation and counteracting depression‐associated neuropathology [29, 55]. This evidence concerns the gene NFKB1 and depressive symptom measurement.